MX2021005526A - Una composicion antimicrobiana para inhibir selectivamente el crecimiento de la bacteria p. acnes. - Google Patents

Una composicion antimicrobiana para inhibir selectivamente el crecimiento de la bacteria p. acnes.

Info

Publication number
MX2021005526A
MX2021005526A MX2021005526A MX2021005526A MX2021005526A MX 2021005526 A MX2021005526 A MX 2021005526A MX 2021005526 A MX2021005526 A MX 2021005526A MX 2021005526 A MX2021005526 A MX 2021005526A MX 2021005526 A MX2021005526 A MX 2021005526A
Authority
MX
Mexico
Prior art keywords
antimicrobial composition
inhibiting growth
selectively inhibiting
acnes
acnes bacteria
Prior art date
Application number
MX2021005526A
Other languages
English (en)
Inventor
Anindya Dasgupta
Sayandip Mukherjee
Sandip Bhanudas Pathak
Original Assignee
Unilever Ip Holdings B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Ip Holdings B V filed Critical Unilever Ip Holdings B V
Publication of MX2021005526A publication Critical patent/MX2021005526A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01017—Lysozyme (3.2.1.17)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La presente invención se relaciona con un método y una composición para prevenir o tratar el acné mediante la inhibición selectiva de la bacteria P. acnes. El método comprende tratar la piel con endolisinas derivadas de fagos de P. acnes y moléculas de ácido nucleico que codifican las mismas en combinación con aceites esenciales selectivos.
MX2021005526A 2018-11-19 2019-11-08 Una composicion antimicrobiana para inhibir selectivamente el crecimiento de la bacteria p. acnes. MX2021005526A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18207026 2018-11-19
PCT/EP2019/080678 WO2020104216A1 (en) 2018-11-19 2019-11-08 An antimicrobial composition for selectively inhibiting growth of p. acnes bacteria

Publications (1)

Publication Number Publication Date
MX2021005526A true MX2021005526A (es) 2021-06-18

Family

ID=64362427

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021005526A MX2021005526A (es) 2018-11-19 2019-11-08 Una composicion antimicrobiana para inhibir selectivamente el crecimiento de la bacteria p. acnes.

Country Status (5)

Country Link
US (1) US20210386835A1 (es)
EP (1) EP3883596A1 (es)
CN (1) CN112996532A (es)
MX (1) MX2021005526A (es)
WO (1) WO2020104216A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023242006A1 (en) * 2022-06-15 2023-12-21 Dsm Ip Assets B.V. Use of uv filters for the treatment of acne

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2414158T3 (es) 2008-10-20 2013-07-18 Unilever Nv Una composición antimicrobiana
MX2016009898A (es) 2014-01-29 2017-01-23 Vyome Biosciences Pvt Ltd Tratamientos para acne resistente.
MX2016010005A (es) * 2014-02-07 2016-10-07 Unilever Nv Una composicion topica.
WO2016130024A1 (en) * 2015-02-13 2016-08-18 Supreme Biotechnologies Limited Endolysin expression platform
WO2018166758A1 (en) * 2017-03-16 2018-09-20 Unilever N.V. An antimicrobial composition comprising essential oil and antimicrobial lipid
JP2020517735A (ja) * 2017-04-21 2020-06-18 ピー・エイチ・アイ・セラピューティクス・インコーポレイテッド ざ瘡を治療するためのプロピオニバクテリウムアクネス（Ｐｒｏｐｉｏｎｉｂａｃｔｅｒｉｕｍ ａｃｎｅｓ）バクテリオファージを含む組成物

Also Published As

Publication number Publication date
CN112996532A (zh) 2021-06-18
EP3883596A1 (en) 2021-09-29
WO2020104216A1 (en) 2020-05-28
US20210386835A1 (en) 2021-12-16

Similar Documents

Publication Publication Date Title
AR087859A1 (es) Metodos y composiciones para el control de malezas
PH12017501019A1 (en) Isoxazole hydromaxamic acid compounds as lpxc inhibitors
PH12014500111A1 (en) Localized disinfection system for large water bodies
MX2021016034A (es) Composiciones y métodos de tratamiento de una afección mediada por th2 usando prevotella.
AR110838A1 (es) Proceso de desamonificación de corriente principal para tratar agua residual que suprime el crecimiento de bacterias oxidantes de nitritos
MX370300B (es) Tratamiento de agua potable.
WO2016014723A8 (en) A method for deammonification process control using ph, specific conductivity, or ammonia
MX2018004274A (es) Metodos y composiciones para contracciones musculares no deseadas o anormales.
MX2020012467A (es) Una composicion antimicrobiana para inhibir selectivamente el crecimiento de bacteria p. acnes.
MX2020005043A (es) Metodo de desinfeccion para agua y aguas residuales.
MX2021004645A (es) Método y sistema para tratar agua de riego.
ZA201901367B (en) Inhibition of olig2 activity
BR112018009870A2 (pt) processo para preservação de alimentos líquidos utilizando tratamento de campo elétrico pulsado
MX2021005526A (es) Una composicion antimicrobiana para inhibir selectivamente el crecimiento de la bacteria p. acnes.
BR112015019200A2 (pt) método para remover ferro de um banho de pré-tratamento
MX2022002414A (es) Composiciones y métodos de control patogénico.
MX368930B (es) Metodo para sanitizar producto fresco.
NZ596339A (en) Use of monochlorourea to treat industrial waters
PH12018500058A1 (en) Fusion molecules
MA39831A (fr) Biocide pour boues
MX2017004632A (es) Mejoras en y relacionadas con el tratamiento del agua, en particular para inhibir el crecimiento de microorganismos.
MY197563A (en) Kimchi for preventing or treating helicobacter pylori-associated diseases
MX2018002936A (es) Metodos y composiciones inhibidoras de incrustacion.
WO2018077711A3 (en) Use of pyraziflumid for controlling sclerotinia spp in seed treatment applications
SE1750160A1 (en) Pool water desinfection